Non-Calcium-Containing Phosphate Binders: Comparing Efficacy, Safety, and Other Clinical Effects

Phosphate-binder therapy for hyperphosphataemia is key to the treatment of patients with chronic kidney disease (CKD)-mineral and bone disorder (MBD). Calcium-free phosphate binders are increasingly favoured since calcium-based agents potentially cause harmful calcium overload and vascular calcifica...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nephron 2012-05, Vol.120 (2), p.c108-c119
Hauptverfasser:	Frazo, Joo M, Adrago, Teresa
Format:	Artikel
Sprache:	eng
Schlagworte:	Calcium - chemistry Chelating Agents - adverse effects Chelating Agents - chemistry Chelating Agents - therapeutic use Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy Evidence-Based Medicine Humans Hyperphosphatemia - complications Hyperphosphatemia - drug therapy Kidney Failure, Chronic - complications Kidney Failure, Chronic - drug therapy Minireview Phosphates - chemistry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!